To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
Daniel A. Heller, PhD
Dr. Heller is developing a method to direct gene therapies to cancerous tissues. He is synthesizing polymer nanoparticles that can target tumors using specific receptors on their surface.
Project Title: "Molecularly imprinted polymeric antibodies for tumor-targeted siRNA delivery"
Institution: Massachusetts Institute of Technology
Sponsor(s) / Mentor(s): Robert S. Langer, ScD
Cancer Type: All cancers
Research Area: Experimental Therapeutics